LLY Jun 2024 370.000 call
| Previous Close | 194.66 |
| Open | 194.66 |
| Bid | 195.15 |
| Ask | 197.30 |
| Strike | 370.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 194.66 - 194.66 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 81 |
Yahoo FinanceAmazon Health: A long play and a search for partners
Amazon Pharmacy is just one of the segments of health that the e-retail giant is pursuing.
ReutersUS judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed three patents related to Teva's rival drug Ajovy. U.S. District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing peptides were invalid. "The Court does not reach this decision nor overturn a jury verdict lightly," Burroughs said.
Motley Fool2 Magnificent Dividend Stocks to Buy Right Now
If you're looking for dividend stocks that can boost your portfolio returns, you should consider high-quality companies that can pay consistent and growing dividends. Two dividend stocks that stand out as strong buys right now are Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO). Here's why these two top-notch dividend stocks are still worth buying, even though they sport premium valuations.
